0 CHECKOUT

Analgesics in South Korea

  • ID: 227080
  • June 2015
  • Region: South Korea
  • 25 pages
  • Euromonitor International

Analgesics had 3% value growth in 2014. Paediatric acetaminophen increased by 4% as other paediatric acetaminophen products from players substituted Tylenol children; Paediatric acetaminophen saw -38% value decline in 2013 when Tylenol children was discontinued during 2013. The brand became available in 2014 which helped value sales of paediatric acetaminophen increased in 2014.

The Analgesics in South Korea report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

ANALGESICS IN SOUTH KOREA

June 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2009-2014
Table 2 Sales of Analgesics by Category: % Value Growth 2009-2014
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2009-2014
Table 4 NBO Company Shares of Analgesics: % Value 2010-2014
Table 5 LBN Brand Shares of Analgesics: % Value 2011-2014
Table 6 Forecast Sales of Analgesics by Category: Value 2014-2019
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2014-2019
Kwang Dong Pharm Co Ltd in Consumer Health (south Korea)
Strategic Direction
Key Facts
Summary 1 Kwang Dong Pharm Co Ltd: Key Facts
Summary 2 Kwang Dong Pharm Co Ltd: Operational Indicators
Company Background
Production
Summary 3 Kwang Dong Pharm Co Ltd: Production Statistics 2014
Competitive Positioning
Summary 4 Kwang Dong Pharm Co Ltd: Competitive Position 2014
Executive Summary
Consumer Health Sees Strong Growth in 2014
New Product Developments and Packaging Innovations Target Niche Consumers
Consumer Health Companies Develop Marketing Strategies
Hypermarkets, Convenience Stores and Drug Stores Become Popular
Consumer Health Will Continue To Grow in the Forecast Period
Key Trends and Developments
New Product Developments and Packaging Innovations Target Specific Consumers
Consumer Health Players Focus on New Marketing Strategies
Diversification of Consumer Health Distribution Channel and Strong Performance of Consumer Health Products Not Sold in Chemists/pharmacies in 2014
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 9 Life Expectancy at Birth 2009-2014
Market Data
Table 10 Sales of Consumer Health by Category: Value 2009-2014
Table 11 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 12 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 13 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 14 Distribution of Consumer Health by Format: % Value 2009-2014
Table 15 Distribution of Consumer Health by Format and Category: % Value 2014
Table 16 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 5 OTC: Switches 2012-2014
Sources
Summary 6 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH